Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Moleculin Biotech (MBRX) Debt Ratio (2017 - 2022)

Moleculin Biotech's Debt Ratio history spans 6 years, with the latest figure at 0.0 for Q4 2022.

  • Quarterly results put Debt Ratio at 0.0 for Q4 2022, up 15.54% from a year ago — trailing twelve months through Dec 2022 was 0.0 (up 15.54% YoY), and the annual figure for FY2022 was 0.0, up 15.54%.
  • Debt Ratio for Q4 2022 was 0.0 at Moleculin Biotech, down from 0.0 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.22 in Q3 2019 to a low of 0.0 in Q1 2021.
  • The 5-year median for Debt Ratio is 0.0 (2019), against an average of 0.04.
  • The sharpest move saw Debt Ratio skyrocketed 1170.69% in 2019, then tumbled 98.37% in 2020.
  • Year by year, Debt Ratio stood at 0.01 in 2018, then tumbled by 57.31% to 0.0 in 2019, then crashed by 31.51% to 0.0 in 2020, then plummeted by 51.76% to 0.0 in 2021, then grew by 15.54% to 0.0 in 2022.
  • According to Business Quant data, Debt Ratio over the past three periods came in at 0.0, 0.0, and 0.0 for Q4 2022, Q3 2022, and Q2 2022 respectively.